Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT Using Integrated Intraprocedural Imaging: the RELIANT 2 Trial
Status: Active_not_recruiting
Location: See all (4) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
RELIANT 2 is a pragmatic randomized controlled trial. The goal of this study is to compare the diagnostic yield of robotic assisted bronchoscopy with integrated cone beam computed tomography to that of electromagnetic navigation bronchoscopy with integrated digital tomosynthesis in patients undergoing bronchoscopy to biopsy a pulmonary lesion.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• ≥ 18 years of age at time of bronchoscopy
• Scheduled for navigational bronchoscopy for the evaluation of a pulmonary lesion
Locations
United States
Illinois
Rush University Medical Center
Chicago
Maryland
Johns Hopkins University
Baltimore
Tennessee
Vanderbilt University Medical Center
Nashville
Vanderbilt University Medical Center
Nashville
Time Frame
Start Date: 2024-11-11
Completion Date: 2026-10-14
Participants
Target number of participants: 440
Treatments
Active_comparator: Robotic assisted bronchoscopy (RAB)
Robotic assisted bronchoscopy with integrated cone beam computed tomography
Active_comparator: Electromagnetic navigation bronchoscopy (ENB)
Electromagnetic navigation bronchoscopy (ENB) with integrated digital tomosynthesis
Related Therapeutic Areas
Sponsors
Leads: Vanderbilt University Medical Center